Stealth Biotech start-up

Envision a world where every human disease is treatable.

This is our mission.

With many of today's therapeutic milestones being inspired by plant-pathogen interactions, an innovative start-up has emerged to harness TSL's world-class research and pioneer transformative advances in human health.

This stealth biotech start-up taps into unconventional approaches, such as ubiquitin-independent protein degradation, to confront some of the toughest medical challenges.

Supported by TSL Ventures